BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6734218)

  • 1. Immunological changes in the organism of patients with myocardial infarction.
    Mirrakhimov MM; Kitaev MI; Dvorkin MI
    Cor Vasa; 1984; 26(2):81-7. PubMed ID: 6734218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prognostic significance of typical immune reactions in myocardial infarction].
    Zemskov AM; Alekhina OD; Zemskov VM; Zemskov MA; Zoloedov VI
    Ter Arkh; 2008; 80(1):32-7. PubMed ID: 18326224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunofluorescent and migration inhibition studies in rats with experimental myocardial infarction.
    Csáky L; Szabó J; Nosztray K; Szegi J
    Acta Physiol Acad Sci Hung; 1976; 47(1):85-9. PubMed ID: 801308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Use of autoallergic reactions for evaluating the immune status of patients with acute coronary insufficiency].
    Dvorkin MI
    Zdravookhr Kirg; 1979; (1):10-5. PubMed ID: 35891
    [No Abstract]   [Full Text] [Related]  

  • 5. [Autoimmune reactions to myoglobin in myocardial infarct patients].
    Mirrakhimov MM; Kitaev MI; Imanbaev AS; Markovich MO
    Ter Arkh; 1984; 56(10):53-6. PubMed ID: 6335308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The clinico-immunological aspects of a repeat myocardial infarct].
    Trofimov GA
    Voen Med Zh; 1992 Sep; (9):32-4. PubMed ID: 1448943
    [No Abstract]   [Full Text] [Related]  

  • 7. Migration-inhibition-test on leucocytes from patients of myocardial infarction.
    Chaturvedi UC; Sharma RK; Mathur A; Ahuja RC
    Indian J Pathol Microbiol; 1977 Oct; 20(4):197-200. PubMed ID: 614248
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of some clinical and laboratory factors influencing immunological response in acute myocardial infarction.
    Hermanowicz A
    Acta Med Pol; 1975; 16(3):197-208. PubMed ID: 1180122
    [No Abstract]   [Full Text] [Related]  

  • 9. Optimal timing of coronary artery bypass after acute myocardial infarction: a review of California discharge data.
    Weiss ES; Chang DD; Joyce DL; Nwakanma LU; Yuh DD
    J Thorac Cardiovasc Surg; 2008 Mar; 135(3):503-11, 511.e1-3. PubMed ID: 18329460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apparently coronary heart disease-free patients in the coronary care unit: characteristics, medical care, and 1-year outcome.
    Brodin EC; Shahar E; Rosamond WD; McGovern PG; Sprafka JM; Doliszny KM; Luepker RV
    Coron Artery Dis; 1994 Sep; 5(9):737-43. PubMed ID: 7858763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The prehospital phase in patients with acute myocardial infarct in Slovakia. A challenge].
    Cagán S; Pavlovic M; Stefanovic R; Murín J; Wimmerová S; Besedová I; Trnovec T
    Vnitr Lek; 2000 Feb; 46(2):67-79. PubMed ID: 11048527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Phagocytic activity of peripheral blood leukocytes during acute myocardial infarction].
    Durdević PM; Baskić DD; Dukić ALj; Popović S; Jakovljević VLj; Arsenijevic NN
    Med Pregl; 2003; 56 Suppl 1():97-102. PubMed ID: 15510922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Humoral and cellular immune responses up to 7.5 years after administration of streptokinase for acute myocardial infarction.
    Squire IB; Lawley W; Fletcher S; Holme E; Hillis WS; Hewitt C; Woods KL
    Eur Heart J; 1999 Sep; 20(17):1245-52. PubMed ID: 10454976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunological diagnosis of myocardial infarct].
    Korochkin IM; Selivanov II; Solov'eva IA; Tabakova TV; Chukaeva II; Chupeeva NG
    Kardiologiia; 1980 May; 20(5):51-3. PubMed ID: 6993752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prognosis after acute coronary syndrome. Lack of difference according to the sex].
    Bounhoure JP; Farah B; Fajadet J; Marco J
    Bull Acad Natl Med; 2004; 188(3):383-97; discussion 397-9. PubMed ID: 15584651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diagnosis of autoimmunization syndromes in cardiology by the leukocyte migration inhibition reaction].
    Hainaut J; Kermarec J; Haguenauer G; Pernod J
    Ann Med Interne (Paris); 1974 Oct; 125(10):711-8. PubMed ID: 4615611
    [No Abstract]   [Full Text] [Related]  

  • 17. [Dynamics of the immunological phenomena in a complicated course of myocardial infarction (Dressler's syndrome)].
    Dvorkin MI
    Zdravookhr Kirg; 1979; (3):17-21. PubMed ID: 38589
    [No Abstract]   [Full Text] [Related]  

  • 18. Relation of antimyocardium antibodies to mortality in patients with acute myocardial infarction.
    Sánchez-Barriga JJ; García-Elorriaga G; González-Bonilla C; Ramos-Corrales MA; Cárdenas-Mondragón MG; Chávez-Rueda AK; García Vigil JL; Blanco-Favela F
    Arch Med Res; 2006 May; 37(4):517-21. PubMed ID: 16624652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The timing of development and subsequent clinical course of heart failure after a myocardial infarction.
    Torabi A; Cleland JG; Khan NK; Loh PH; Clark AL; Alamgir F; Caplin JL; Rigby AS; Goode K
    Eur Heart J; 2008 Apr; 29(7):859-70. PubMed ID: 18353754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Predictive factors for survival and for a second coronary event in patients with a first acute myocardial infarct].
    Rodríguez-Abrego G; Escobedo-de la Peña J; Unzueta Montoya A
    Arch Inst Cardiol Mex; 1997; 67(1):38-45. PubMed ID: 9221709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.